Scholarship Program Awards Students Across the Country Impacted
by Dermatologic Conditions
LAVAL, Quebec, Nov. 14, 2017 /CNW/ -- Ortho Dermatologics,
a division of Valeant Pharmaceuticals International, Inc. (NYSE:
VRX and TSX: VRX), today announced the nine recipients of the
Aspire Higher Scholarship program, which honors the achievements of
applicants or current attendees of an accredited, nonprofit, two-
or four-year college, university, or advanced (post-high school)
vocational or technical school who have been treated for a
dermatologic condition.
"Since 2013, the Ortho Dermatologics Aspire Higher Scholarship
program has recognized students that have not allowed skin
conditions like psoriasis, eczema and severe acne to stand in the
way of their academic achievements. We're proud to support these
exemplary individuals as they continue their studies," said
Joseph C. Papa, chairman and CEO of
Valeant.
Three scholarships were awarded in each of three categories:
Undergraduate Scholar Awards for students pursuing an undergraduate
degree, Graduate Scholar Awards for students pursuing a graduate
degree and Today's Woman Scholar Awards for students who are
mothers pursuing higher education. A panel of judges consisting of
dermatologists from across the country reviewed each of the
applications and chose the nine honorees.
To apply for the scholarship, applicants were asked to submit an
essay discussing how their dermatologic condition, and the
subsequent treatment received by their dermatologist, physician
assistant, or nurse practitioner, has impacted their life. The
nine honorees were chosen from a pool of 2,179 applicants and will
each receive $10,000 towards their
education.
The nine recipients of the 2017 Aspire Higher scholarship
program are:
Undergraduate student winners - for students pursuing an
undergraduate degree.
- Jordan Johnson of Friendswood, Texas, who will attend the
University of Arkansas
- Robert (Robby) Ruffolo of
Dayton, Ohio, who will attend the
University of North Carolina (Chapel
Hill)
- Meredith Richards of
Kinderhook, New York, who is
currently enrolled at Utah State
University
Graduate student winners - for students pursuing a graduate
degree.
- Madeline Gore of Lakeville, Minnesota, who will attend
Loyola University of Chicago
- Braden Candela of Rochester, New York, who is currently enrolled
at the University of Rochester School of
Medicine & Dentistry
- Shulei (Shelley) Chen of
Walnut, California, who is
currently enrolled at UC Berkeley – UCSF Joint Medical Program
Today's Woman Scholar winners - for students who are mothers
and pursuing an undergraduate or graduate degree.
- Amy Feldman of South Jordan, Utah, who is currently enrolled
at Brigham Young University
- Bianca Bzdel of Mill Valley, CA, who is currently enrolled at
the University of California Davis
- Carine Henderson of Sandy, Utah, who has been accepted to the
graduate program at Brigham Young
University
Since 2013, the Aspire Higher scholarship program has awarded 23
scholarships to students across the country.
Additional information about the Ortho Dermatologics Aspire
Higher scholarship program can be found at
www.AspireHigherScholarships.com. The 2018 program will begin
accepting applications in early 2018.
About Ortho Dermatologics
Ortho Dermatologics,
aValeant Pharmaceuticals International, Inc. company, is one
of the largest prescription dermatology businesses in the world
dedicated to helping patients in the treatment of a range of
therapeutic areas including actinic keratosis, acne, atopic
dermatitis, cold sores, athlete's foot, nail fungus and other
dermatoses. The Ortho Dermatologics portfolio includes several
leading acne, anti-fungal and anti-infective products. More
information can be found at www.ortho-dermatologics.com.
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of dermatology,
gastrointestinal disorders, eye health, neurology and branded
generics. More information about Valeant can be found
at www.valeant.com.
Forward-looking Statements
This press release may
contain forward-looking statements which may generally be
identified by the use of the words "anticipates, "expects,"
"intends," "plans," "should," "could," "would," "may," "will,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, risks and uncertainties discussed in the Company's most
recent annual or quarterly report and detailed from time to time in
Valeant's other filings with the Securities and Exchange Commission
and the Canadian Securities Administrators, which factors are
incorporated herein by reference. Readers are cautioned not to
place undue reliance on any of these forward-looking statements.
These forward-looking statements speak only as of the date hereof.
Valeant undertakes no obligation to update any of these
forward-looking statements to reflect events or circumstances after
the date of this press release or to reflect actual outcomes,
unless required by law.
Contact
Information:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
514-856-3855
|
908-927-0617
|
877-281-6642 (toll
free)
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/ortho-dermatologics-announces-aspire-higher-scholarship-honorees-300553519.html
SOURCE Valeant Pharmaceuticals International, Inc.